(Q41197818)

28 September 2017

1 reference

title

Use of cyclosporine A in the treatment of refractory nephrotic syndrome in adults (English)

1 reference

28 September 2017

1 reference

1 reference

Meyrier A

1

1 reference

28 September 2017

publication date

1 September 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

18

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

775-784

1 reference

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

The nephrotic syndrome and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

Management of nephrotic syndrome in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

Mechanisms of proteinuria in noninflammatory glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08860229609047706

10.3109/08860229609047706

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference